Androgen responsive and refractory prostate cancer cells exhibit distinct curcumin regulated transcriptome

Cancer Biology & Therapy
Rajesh L ThangapazhamRadha K Maheshwari

Abstract

Curcumin (diferuloylmethane) is the major active component of turmeric and is being actively investigated for its anti-cancer properties. To better understand the biological mechanisms of the chemopreventive potential of curcumin in prostate cancer, we have evaluated curcumin regulated transcriptome in prostate cancer cells. Hierarchical clustering methods and functional classification of the Curcumin-Gene Expression Response (Cu-GER) showed temporal co-regulation of genes involved in oxidative stress response and growth signaling pathways. Interestingly, C4-2B, androgen independent metastatic prostate cancer cells exhibited attenuated Cu-GER response in comparison to parental androgen dependent and less aggressive LNCaP cells. Androgen Receptor (AR) regulated genes which play critical roles in normal growth and differentiation of the prostate gland, as well as in prostate cancer, were also a part of the Cu-GER. Of note, curcumin downregulated transcript encoded by the potentially causal TMPRSS2-ERG gene fusion, a common oncogenic alteration noted in 50-70% of prostate cancer patients. Further more, expression of EGFR and ERBB2 receptor were found to be downregulated in curcumin treated LNCaP and C4-2B cells. This report for th...Continue Reading

Citations

Oct 7, 2009·Genes & Nutrition·Marie-Hélène TeitenMarc Diederich
May 24, 2012·The Oncologist·Samuel J Klempner, Glenn Bubley
Jul 3, 2010·Cancer·Siqing Fu, Razelle Kurzrock
Jun 4, 2013·Biochemical and Biophysical Research Communications·Misaki OnoShuji Nakano
Nov 9, 2012·Korean journal of urology·Shigeo Horie
Apr 9, 2011·The American Journal of Chinese Medicine·Ebtesam A Al-SuhaimiReham A Al-Essa
Oct 5, 2019·International Journal of Molecular Sciences·Shilpa KattaShashwat Sharad
Aug 14, 2019·European Journal of Medicinal Chemistry·A GolonkoW Lewandowski
Nov 14, 2020·Biomolecules·Deborah TerminiEvangelia Tsiani
May 25, 2021·Frontiers in Pharmacology·Bruna A C RattisMara R N Celes

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer -Omics

A variety of different high-throughput technologies can be used to identify the complete catalog of changes that characterize the molecular profile of cohorts of tumor samples. Discover the latest insights gained from cancer 'omics' in this feed.